AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

Heidelberg, Germany, Sept. 13 (Korea Bizwire) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects.  With this expansion, AGC Biologics is boosting its current 100L and 1,000L manufacturing capacities for a variety [...]